Roser Velasco (R Velasco)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 21

Top Topics

Myasthenia Gravis

Hodgkin Lymphoma

Top Venues

European journal of neurology

Journal of the peripheral nervous system : JPNS

Journal of clinical medicine

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Roser Velasco, Haralabos P Kalofonos, David R Cornblath, Pere Bruna, Paola Alberti, Emanuela Rossi, Ingemar S J Merkies, Dimitri Psimaras, Chiara Briani, Roy I Lalisang, Angelo Schenone, Guido Cavaletti, Jordi Bruna, null null
Repurposing chemotherapy-induced peripheral neuropathy grading. European journal of neurology (2024)
Roser Velasco, Carla Marco, Eva Domingo-Domenech, Agostina Stradella, Cristina Santos, Berta Laquente, German Ferrer, Andreas A Argyriou, Jordi Bruna
Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug. European journal of neurology 31 (9) (2024)
Roser Velasco, Carla Marco, Eva Domingo-Domenech, Agostina Stradella, Cristina Santos, Berta Laquente, German Ferrer, Andreas A Argyriou, Jordi Bruna
Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug. European journal of neurology 31 (9) (2024)
Roser Velasco, Carla Marco, Eva Domingo-Domenech, Agostina Stradella, Cristina Santos, Berta Laquente, German Ferrer, Andreas A Argyriou, Jordi Bruna
Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug. European journal of neurology (2024)
Roser Velasco, Carla Marco, Eva Domingo-Domenech, Agostina Stradella, Cristina Santos, Berta Laquente, German Ferrer, Andreas A Argyriou, Jordi Bruna
Plasma neurofilament light chain levels in chemotherapy-induced peripheral neurotoxicity according to type of anticancer drug. European journal of neurology 31 (9) (2024)
Carla Marco, Ariadna Padró-Miquel, Eva Domingo-Domenech, Roser Velasco
Comment on: Brentuximab vedotin-related neuropathy in a patient with Gilbert syndrome: Do mutations of UGT1A1 gene affect brentuximab toxicity? Pediatric blood & cancer (2023)
Albert Pons-Escoda, Pablo Naval-Baudin, Roser Velasco, Noemí Vidal, Carles Majos
Imaging of Lymphomas Involving the CNS: An Update-Review of the Full Spectrum of Disease with an Emphasis on the World Health Organization Classifications of CNS Tumors 2021 and Hematolymphoid Tumors 2022. AJNR. American journal of neuroradiology (2023)
Carla Marco, Marta Simó, Montse Alemany, Carlos Casasnovas, Raúl Domínguez, Noelia Vilariño, Mariona Calvo, Juan Martín-Liberal, Jesús Brenes, Joan Sabater-Riera, Jordi Bruna, Roser Velasco
Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of clinical medicine 12 (1) (2022)
Carla Marco, Marta Simó, Montse Alemany, Carlos Casasnovas, Raúl Domínguez, Noelia Vilariño, Mariona Calvo, Juan Martín-Liberal, Jesús Brenes, Joan Sabater-Riera, Jordi Bruna, Roser Velasco
Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of clinical medicine 12 (1) (2022)
Miguel Angel Rubio, Mireia Herrando-Grabulosa, Roser Velasco, Israel Blasco, Monica Povedano, Xavier Navarro
TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients. Cells 11 (2) (2022)
Roser Velasco, A A Argyriou, C Marco, S Mariotto, A Stradella, J Hernández, S Pernas, S Ferrari, J Bruna
Serum neurofilament levels correlate with electrodiagnostic evidence of axonal loss in paclitaxel-induced peripheral neurotoxicity. Journal of neurology (2022)
Carla Marco, Marta Simó, Montse Alemany, Carlos Casasnovas, Raúl Domínguez, Noelia Vilariño, Mariona Calvo, Juan Martín-Liberal, Jesús Brenes, Joan Sabater-Riera, Jordi Bruna, Roser Velasco
Myasthenia Gravis Induced by Immune Checkpoint Inhibitors: An Emerging Neurotoxicity in Neuro-Oncology Practice: Case Series. Journal of clinical medicine 12 (1) (2022)
Paola Alberti, Davide P Bernasconi, David R Cornblath, Ingemar S J Merkies, Susanna B Park, Roser Velasco, Jordi Bruna, Dimitri Psimaras, Susanne Koeppen, Andrea Pace, Susan G Dorsey, Haralabos P Kalofonos, Haralabos P Kalofonos, Chiara Briani, Angelo Schenone, Catharina G Faber, Anna Mazzeo, Wolfgang Grisold, MariaGrazia Valsecchi, Guido Cavaletti, null null
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity. Neurology 97 (7) (2021)
Roser Velasco, Montserrat Alemany, Macarena Villagrán, Haralabos P Kalofonos
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity. Journal of personalized medicine 11 (7) (2021)
Roser Velasco, Eva Domingo-Domenech, Anna Sureda
Brentuximab-Induced Peripheral Neurotoxicity: A Multidisciplinary Approach to Manage an Emerging Challenge in Hodgkin Lymphoma Therapy. Cancers 13 (23) (2021)
Roser Velasco, Paola Alberti, Jordi Bruna, Dimitri Psimaras, Andreas A Argyriou
Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: From pathogenesis to treatment. Journal of the peripheral nervous system : JPNS (2020)
Roser Velasco, S Mercadal, N Vidal, M Alañá, M I Barceló, M J Ibáñez-Juliá, S Bobillo, R Caldú Agud, E García Molina, P Martínez, P Cacabelos, A Muntañola, G García-Catalán, J M Sancho, I Camro, T Lado, M E Erro, L Gómez-Vicente, A Salar, A C Caballero, M Solé-Rodríguez, J Gállego Pérez-Larraya, N Huertas, J Estela, M Barón, N Barbero-Bordallo, M Encuentra, I Dlouhy, J Bruna, F Graus, null null
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study. Journal of neuro-oncology 148 (3) (2020)
Dimitri Psimaras, Roser Velasco, Cristina Birzu, Stefano Tamburin, Maryam Lustberg, Jordi Bruna, Andreas A Argyriou
Immune checkpoint inhibitors-induced neuromuscular toxicity: From pathogenesis to treatment. Journal of the peripheral nervous system : JPNS (2020)
Jordi Bruna, Haralabos P Kalofonos, Garifallia G Anastopoulou, Montse Alemany, Ernest Nadal, Foteini Kalofonou, Josep M Piulats, Marta Simó, Roser Velasco, Haralabos P Kalofonos
Incidence and characteristics of neurotoxicity in immune checkpoint inhibitors with focus on neuromuscular events: Experience beyond the clinical trials. Journal of the peripheral nervous system : JPNS 25 (2) (2020)
Haralabos P Kalofonos, Anna G Antonacopoulou, Paola Alberti, Chiara Briani, Jordi Bruna, Roser Velasco, Garifallia G Anastopoulou, Susanna B Park, Guido Cavaletti, Haralabos P Kalofonos
Liability of the voltage-gated potassium channel KCNN3 repeat polymorphism to acute oxaliplatin-induced peripheral neurotoxicity. Journal of the peripheral nervous system : JPNS 24 (4) (2019)
Sarah Besora, Cristina Santos, Cristina Izquierdo, Maria Mercedes Martinez-Villacampa, Jordi Bruna, Roser Velasco
Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients. Journal of cancer research and clinical oncology 144 (9) (2018)